Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.
about
The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in CancerTreatment of oral squamous cell carcinoma using anti-HER2 immunonanoshells.Screening and Identification of a Phage Display Derived Peptide That Specifically Binds to the CD44 Protein Region Encoded by Variable Exons.The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxinImmunonanoshells for targeted photothermal ablation of tumor cellsAnticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study.Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?Perspectives of CD44 targeting therapies.Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells.An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors.The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer.Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers.CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.Evaluation of interstitial protein delivery in multicellular layers model.
P2860
Q26747319-BC40E11B-FD02-412C-B9FB-A6E4D5D140E4Q34087477-C48A92EF-5832-4163-8999-B227AD4A369AQ35794084-0C1D59DC-C02F-4F4B-9D1D-21EADD942287Q35888664-16167406-7420-4734-9FB1-9707276FDC71Q35947656-6D6A2167-0B0F-4DE6-B092-88AB700B0182Q36717996-619CF77A-72FB-4070-BAB4-D1BA47EE55ECQ37188974-CA0CACE0-FBB3-4519-A41E-BC318999FEE9Q37666618-21ABD913-871A-4FEE-83D9-FC24BEC4A515Q37684670-CE0278CB-C5A8-4F44-8478-BD88FEA8B5A6Q37976121-4326E483-FE7D-4E64-BAD9-1B0CBEF830F5Q38282790-E2BE3468-0377-4441-AD2C-5F10FEB3AA10Q39388913-6645E294-B85D-4E08-9887-69A3B01F5FF6Q39720680-9DE39FBD-39B1-49C9-AD5A-8A031949B7F5Q39866556-40F87E01-2A09-47B7-96CB-6A10DEEBE04CQ40144418-34D84112-BEBA-438A-BECC-B8C009EB1581Q42371513-657360A4-48A1-48B7-AA40-7D6A14A2A066Q43376023-8D2E0FFF-C36B-48C8-B13C-759AB83A19CBQ53381586-3AAEE656-FE58-4C2D-9EE7-971920B7E900
P2860
Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Tumor targeting properties of ...... ad-and-neck cancer xenografts.
@en
Tumor targeting properties of ...... ad-and-neck cancer xenografts.
@nl
type
label
Tumor targeting properties of ...... ad-and-neck cancer xenografts.
@en
Tumor targeting properties of ...... ad-and-neck cancer xenografts.
@nl
prefLabel
Tumor targeting properties of ...... ad-and-neck cancer xenografts.
@en
Tumor targeting properties of ...... ad-and-neck cancer xenografts.
@nl
P2093
P2860
P356
P1476
Tumor targeting properties of ...... ad-and-neck cancer xenografts.
@en
P2093
Elínborg Ostermann
Erik Patzelt
Gordon B Snow
Guus A M S van Dongen
Günther R Adolf
Iris Verel
Karl-Heinz Heider
Marlies Sproll
Miranda Siegmund
P2860
P304
P356
10.1002/IJC.10369
P577
2002-05-01T00:00:00Z